The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands

Autor: Salvatore Moricca, Ettore Novellino, Vittorio Colantuoni, Carmen Cerchia, Pamela Ziccardi, Sabrina Dallavalle, Antonio Lavecchia, Tommaso Colangelo, Fabrizio Dal Piaz, Angelo Lupo, Diana Zurlo, Carolina Votino
Přispěvatelé: Zurlo, Diana, Ziccardi, Pamela, Votino, Carolina, Colangelo, Tommaso, Cerchia, Carmen, Dal Piaz, Fabrizio, Dallavalle, Sabrina, Moricca, Salvatore, Novellino, Ettore, Lavecchia, Antonio, Colantuoni, Vittorio, Lupo, Angelo
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Protein Conformation
Peroxisome proliferator-activated receptor
Apoptosis
Naphthols
Ligands
Biochemistry
Docking
Transactivation
0302 clinical medicine
Anilides
chemistry.chemical_classification
Tumor
Stereoisomerism
Cell biology
Cladosporols
Colorectal cancer cells
Full and partial PPARγ agonists
Antineoplastic Agents
Cell Line
Tumor

Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p21
Drug Partial Agonism
G1 Phase Cell Cycle Checkpoints
HEK293 Cells
Humans
Molecular Docking Simulation
Oxidative Stress
PPAR gamma
Protein Binding
Structure-Activity Relationship
Transcriptional Activation
Pharmacology
030220 oncology & carcinogenesis
Retinoid X receptor
Biology
Partial agonist
Cell Line
03 medical and health sciences
Structure–activity relationship
Cell growth
HEK 293 cells
Apoptosi
Cladosporol
030104 developmental biology
chemistry
Docking (molecular)
Colorectal cancer cell
Popis: Cladosporols are secondary metabolites from Cladosporium tenuissimum characterized for their ability to control cell proliferation. We previously showed that cladosporol A inhibits proliferation of human colon cancer cells through a PPARγ-mediated modulation of gene expression. In this work, we investigated cladosporol B, an oxidate form of cladosporol A, and demonstrate that it is more efficient in inhibiting HT-29 cell proliferation due to a robust G0/G1-phase arrest and p21(waf1/cip1) overexpression. Cladosporol B acts as a PPARγ partial agonist with lower affinity and reduced transactivation potential in transient transfections as compared to the full agonists cladosporol A and rosiglitazone. Site-specific PPARγ mutants and surface plasmon resonance (SPR) experiments confirm these conclusions. Cladosporol B in addition displays a sustained proapoptotic activity also validated by p21(waf1/cip1) expression analysis in the presence of the selective PPARγ inhibitor GW9662. In the DMSO/H2O system, cladosporols A and B are unstable and convert to the ring-opened compounds 2A and 2B. Finally, docking experiments provide the structural basis for full and partial PPARγ agonism of 2A and 2B, respectively. In summary, we report here, for the first time, the structural characteristics of the binding of cladosporols, two natural molecules, to PPARγ. The binding of compound 2B is endowed with a lower transactivation potential, higher antiproliferative and proapoptotic activity than the two full agonists as compound 2A and rosiglitazone (RGZ).
Databáze: OpenAIRE